Primary lung cancer in never smokers

被引：0

作者：

Yoshihiko Maehara

机构：

[1] Kyushu University,Department of Surgery and Science, Graduate School of Medical Sciences

来源：

International Journal of Clinical Oncology | 2011年 / 16卷

关键词：

Lung Cancer; Epidermal Growth Factor Receptor; Gefitinib; Tyrosine Kinase Inhibitor; Cancer Death Rate;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：285 / 286

页数：1

共 17 条

[1]

Jemal A(2010)Cancer statistics, 2010 CA Cancer J Clin 60 277-300

[2]

Siegel R(2007)Lung cancer incidence in never smokers J Clin Oncol 25 472-478

[3]

Xu J(2007)Lung cancer in never smokers: a review J Clin Oncol 25 561-570

[4]

Wakelee HA(2008)Never-smoking non-small cell lung cancer as a separate entity—the clinico-pathologic features and survival Cancer 113 1012-1018

[5]

Chang ET(2009)Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma N Engl J Med 361 947-957

[6]

Gomez SL(2009)Clinical features and outcome of patients with non-small-cell lung cancer who harbor J Clin Oncol 27 4247-4253

[7]

Subramanian J(undefined)- undefined undefined undefined-undefined

[8]

Govindan R(undefined)undefined undefined undefined undefined-undefined

[9]

Yano T(undefined)undefined undefined undefined undefined-undefined

[10]

Miura N(undefined)undefined undefined undefined undefined-undefined